Mycobacterium ulcerans disease (Buruli ulcer) is the most widespread mycobacterial disease in the world after leprosy and tuberculosis. How M. ulcerans is introduced into the skin of humans remains unclear, but it appears that individuals living in the same environment may have different susceptibilities.
This study aims to determine whether frequent contacts with natural water sources, family relationship or the practice of consanguineous marriages are associated with the occurrence of Buruli ulcer (BU).
BU-confirmed cases that were diagnosed and followed up at the BU detection and treatment center (CDTUB) of Allada (Department of the Atlantique, Benin) during the period from January 1st, 2006, to June 30th, 2008, with three matched controls (persons who had no signs or symptoms of active or inactive BU) for age, gender and village of residence per case.
Main Outcomes Measured
Contact with natural water sources, BU history in the family and the practice of consanguineous marriages.
A total of 416 participants were included in this study, including 104 cases and 312 controls. BU history in the family (p<0.001), adjusted by daily contact with a natural water source (p = 0.007), was significantly associated with higher odds of having BU (OR; 95% CI = 5.5; 3.0–10.0). The practice of consanguineous marriage was not associated with the occurrence of BU (p = 0.40). Mendelian disorders could explain this finding, which may influence individual susceptibility by impairing immunity.
Mycobacterium ulcerans disease (Buruli ulcer) is the most widespread mycobacterial disease in the world after leprosy and tuberculosis. How M. ulcerans is introduced into the skin of humans remains unclear, but it appears that individuals living in the same environment may have different susceptibilities. This case control study aims to determine whether frequent contacts with natural water sources, family relationship or the practice of consanguineous marriages are associated with the occurrence of Buruli ulcer (BU). The study involved 416 participants, of which 104 BU-confirmed cases and 312 age, gender and village of residence matched controls (persons who had no signs or symptoms of active or inactive BU). The results confirmed that contact with natural water sources is a risk factor. Furthermore, it suggests that a combination of genetic factors may constitute risk factors for the development of BU, possibly by influencing the type of immune response in the individual, and, consequently, the development of BU infection per se and its different clinical forms. These findings may be of major therapeutic interest.
Citation: Sopoh GE, Barogui YT, Johnson RC, Dossou AD, Makoutodé M, Anagonou SY, et al. (2010) Family Relationship, Water Contact and Occurrence of Buruli Ulcer in Benin. PLoS Negl Trop Dis 4(7): e746. https://doi.org/10.1371/journal.pntd.0000746
Editor: Richard O. Phillips, Kwame Nkrumah University of Science and Technology (KNUST) School of Medical Sciences, Ghana
Received: March 17, 2010; Accepted: May 28, 2010; Published: July 13, 2010
Copyright: © 2010 Sopoh et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors are grateful to all the partners who support the PNLLUB and the CDTUB Allada, in particular the following: 1. Government of Benin; 2. Raoul Follereau Foundation of Luxembourg; 3. Burulico Project (European Union project INCO-CT-2005-051476); 4. Stop Buruli project (UBS Optimus Foundation), Switzerland; 5. Damien Action, Brussels, Belgium; 6. Directorate-General for Development and Cooperation (DGDC), Brussels, Belgium; 7. World Health Organization (WHO), Geneva, Switzerland. The funders had no role in study design, data collection, data analysis, data interpretation, decisions to publish or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Mycobacterium ulcerans disease, commonly named Buruli Ulcer (BU), is the most common mycobacterial disease in the world after leprosy and tuberculosis. This emerging disease has been reported in more than 30 countries in Africa, Latin America, Oceania and Asia  causing immense human suffering , , while its prevalence in most endemic countries is uncertain . How exactly M. ulcerans is introduced into the skin of humans remains unknown, but in contrast to tuberculosis (TB) or leprosy, the infection is acquired directly or indirectly from the environment and not through contact with other patients . There is now evidence that M. ulcerans is an environmental pathogen transmitted to humans from aquatic sources, and the first isolation and characterization of an M. ulcerans strain from an aquatic Hemiptera (water striders, Gerris sp.) from Benin was reported by Portaels et al. . The individuals living in the same environment appear to have different susceptibilities to the disease. Indeed, most individuals exposed to M. ulcerans never develop BU disease .The reason why some individuals, but not others, exposed to M. ulcerans develop BU is unknown but it could be linked to individual differences in innate and acquired immune responses to infection by this bacterium. Furthermore, the susceptibility to the development of BU may be determined by genetic factors as well. Several studies have been conducted to determine the genetic and/or immunological factors affecting BU disease –, but no studies have examined family relationship as a factor of presumptive susceptibility to BU. The aim of our study was to determine whether the occurrence of BU is associated with family relationship or the practice of consanguineous marriage, in addition to daily contact with natural water sources.
Materials and Methods
Study design and participants
A case control study was carried out during the period of January 1st to June 30th, 2008.
The patients included in this study as cases were diagnosed and followed up at the BU detection and treatment center (CDTUB) of Allada (Department of the Atlantique, Benin) or at various health care centers (HCC) involved in the treatment of BU under the supervision of the CDTUB of Allada. From January 2006 to June 2008, the cases with active BU lesions (nodule, edema, plaque, ulcer or osteomyelitis) were recruited  and confirmed by at least one laboratory test (direct smear examination showing acid-fast bacilli, positive culture or IS2404-PCR) . The individuals who were no longer hospitalized were located by using the addresses in their medical file. Eligible cases who had moved or were not found during the data collection were excluded. All eligible cases who were not living in the Atlantique department were also excluded.
An eligible control was defined as a person who had no signs or symptoms of active or inactive BU. The eligible controls who were suffering or had suffered from any mycobacterial disease (leprosy, TB or BU) were excluded as well. Three controls, matched by age, gender and village of residence, were selected for each case. The controls were randomly sampled from within the village of the case according to the matching criteria. A door-to-door systematic procedure was used for control selection from the center of the village of each related case.
We used power calculation tools to determine the sample size. We set alpha equal to 0.05 and power equal to 80%. We assumed a rate of three controls per case. Because we lacked data on the frequency of consanguineous marriages, we assumed a rate of 50% in controls. The minimum of the odds ratio (OR) for the association between cases and controls was set equal to two. We obtained a sample size of 396 participants, including 99 cases and 297 controls.
A standard questionnaire was administered to eligible cases and matched controls (or their guardians) by trained investigators. Structured interviews were conducted with the participants during home visits using the pre-tested questionnaire translated in Aïzo and Fon (the most commonly spoken languages in the region). Interviews with current in-patients were conducted in the hospital. The questionnaire was filled out by the interviewer. If required, subsequent interviews were conducted until all the required data were obtained.
The participant's identification data (age, gender, geographical origin), family history regarding any disease (especially sickle cell disease, diabetes and arterial hypertension), marital status (single or not) and habits regarding daily contact (contacts from professional or domestic activities and, in the case of children, from play activities) with natural sources of water (e.g., river, lake, lagoon, swamp) were collected. The data relating to the illness (clinical form, site and categorization of the lesion based on the World Health Organization (WHO) definition ) were also collected.
The family history of BU in the participant was investigated and if present, the number of family members who had BU was recorded. For each family member who had BU, the data were collected on the degree of the relationship with the participant (grandparents, parents, collaterals and descendants), the residence at the time he/she was ill (same house, same village but not the same house or other village or town) and whether or not he/she had daily contact with a natural water source during his/her daily activities.
The data were collected on the existence or practice of consanguineous marriages. When found, the type of relationship between the married couple (brother/sister, cousins, parents/children, uncle/niece or aunt/nephew) and the degree of the relationship in the consanguineous married couple to the participant were determined.
The pedigree of each participant was determined (with the help of the parents or guardians) using an in depth interview. The pedigrees went as far back or forward as the 3rd generation before or after the participant, when applicable, and included the collaterals. Every parent who had BU was carefully specified.
Statistical and data analyses
The data were recorded and analyzed using epiinfo 3.5.1 (Database and statistics software for public health professionals, Centers for Disease Control and Prevention (CDC), Atlanta, USA).
First, a descriptive univariate analysis was conducted on the characteristics of the participants, using Pearson's chi-square test or Fisher test. Second, the cases and the controls were compared using both univariate and multivariate analysis to determine the odds ratio (OR) and its 95% confidence interval (95% CI). To examine the association between family relationships and the occurrence of BU, all variables were included in a multiple conditional logistic regression model, followed by a step by step backward elimination based on the likelihood ratio in which only significant predictors were retained”. The participant status (case or control) was the dependent variable; all other variables were used as independent variables. Non Respondents have been excluded from the multiple conditional logistic regression analysis.
The study enrollment was voluntary. A written informed consent was obtained from the cases and the controls or from their parents or guardians (for patients younger than 15 years). All BU cases had received or were currently receiving free treatment for BU according to the WHO's recommended protocol . The study protocol was authorized by the Ministry of Health of Benin.
There were 416 participants in the study, including 104 cases and 312 controls.
Among the cases, the median age was 12 years (2 to 68 years). A total of 62 patients (59.6%) were <15 years and 58.7% (61 out of 104) were male. A total of 75 (72.1%) patients came from the Zê district, while 10 (9.6%) came from Allada, 9 (8.7%) from Toffo, 6 (5.8%) from So-Ava, 3 (2.9%) from Abomey-Calavi and 1 (1.0%) from Tori-Bossito. The age, gender and geographical origin were similar for the cases and the controls because of the matching protocol used in control selection. There were no statistical differences between the cases and the controls with regard to marital status, hereditary disease history and daily contact with natural sources of water (Table 1).
With respect to clinical form, 56 cases (53.8%) had ulcerative lesions and 48 cases (46.2%) had non-ulcerative lesions. Lesions were on the lower limbs for 55 cases (52.9%), the upper limbs for 34 (32.7%) and on the trunk for 10 (9.6%). There were four cases with lesions on multiple sites (3.8%) and one case (1.0%) with a lesion on the face. The categorization of patient lesions based on the WHO definition  placed 10 (9.6%) in category 1, 59 (56.7%) in category 2 and 35 (33.7%) in category 3 (data not shown).
Association between family relationships and the occurrence of Buruli ulcer: univariate and multivariate analyses
Table 2 shows the association between family relationships and the occurrence of BU based on the univariate and multivariate analyses. The univariate analysis showed that BU history in the family and daily contact with natural water source were strongly associated with an increased risk of BU (OR; 95% CI = 5.07; 2.81–9.14 and 2.31; 1.18–4.53 respectively). A consanguineous marriage in the family was not associated with the occurrence of BU (p = 0.33). In the multivariate conditional logistic regression model including participant characteristics, two main factors were retained and associated with the occurrence of BU: (1) daily contact with natural source of water (OR; 95% CI = 2.7; 1.3–5.5); (2) BU history in the family (OR; 95% CI = 5.5; 3.0–10.0).
Table 3 shows the degree of the relationship between the cases and any other family member with BU. Associations between family relationships (parents, siblings, cousins, sons, daughters, nieces and nephews) and the occurrence of BU were not found. But, the BU cases were more likely to have grandparents with BU than the controls (p = 0.06). However, there was a lack of precision, the 95% CI being too large (95% CI = 0.85–64.08).
Seven grandparents had a history of BU, six from cases and one from a control. The grandfather was involved three times and the grandmother four times. From seven affected grandparents, two were currently living in the same house, two were living in the same village (but not in the same house), two were living outside the village (including the grandparent of the control) and one was deceased. At the time of the disease, three of the involved grandparents were living in the same house as the patient, two in the same village and one outside the village. The place of residence at the time of the disease was not known for one grandparent. There was no statistical difference with regard to the living places of the grandparents involved between cases and controls (p = 0.30, Fisher test). All grandparents related to a BU case had contact with a natural source of water during their daily activities (data not shown).
The objective of this study was to investigate whether or not daily contact with natural sources of water combined with family relationships was associated with an increased susceptibility to the development of BU. Our major finding was that the odds ratio of having BU was three times higher in the cases than the controls for those having a daily contact with natural sources of water, and five times higher for those who had a history of BU in their family.
Many publications have reported a relationship between BU and neighborhoods in humid environments (reviewed in –). Lunn et al. in 1965  and also Barker in 1972  described cases that were primarily from the Nile Valley and bordering marshes in Uganda. Ravisse in 1975 described cases in Cameroon originating from the Nyong River and surrounding swamps . In 1976, Oluwasanmi described cases in Nigeria that were located in an area near an artificial lake bordering the University of Ibadan . In 2005, Johnson et al. showed that there was an inverse relationship between the prevalence of BU and the distance from the Couffo River in Benin . In 2008, Kibadi et al. reported three patients originating from villages near the Cuango and Kwango River in Angola and the Democratic Republic of Congo, respectively . Thus, it is clear from these studies that M. ulcerans disease occurs mainly in areas located near rivers, lakes or swamps.
Nontuberculous mycobacteria (NTM) can be found everywhere in nature and at all latitudes. In BU endemic areas of Benin, M. ulcerans DNA has been detected in several aquatic organisms –. Humans and animals are regularly in contact with the environmental mycobacteria. Consequently, the colonization of healthy individuals by NTM is fairly common . It is thus important to know why some individuals develop the disease while others do not.
In addition, we have shown, for the first time, the existence of family associations with BU. Previous studies have incorporated BU history in the family among the factors tested but did not find a statistically significant association , , . In contrast to the other studies, we included several generations (e.g., grandparents, parents, children) in our study, which might explain the discrepancies. The observed association of BU history in the family and the occurrence of the disease provide new evidence with regard to the susceptibility to BU. This association may be due to the fact that members of the same family have perhaps same habits and same exposure to common environmental sources. However, we did not find any association between family members of the contemporaneous generations (collaterals, parents or children). This leads us to suggest that genetic factors may increase susceptibility to the BU disease.
Several studies have shown that susceptibility to other mycobacterial infections, such as TB and leprosy, involve a major genetic component that determines the susceptibility of animals and humans to these infections –. In these studies, the development of TB or leprosy upon exposure to the mycobacteria and the pattern of clinical manifestations displayed by patients (pulmonary TB, paucibacillary or multibacillary leprosy) were highly dependent on human genes –, , . Genetic susceptibility to the development of BU was demonstrated by Stienstra et al. , . A similar pattern had previously been found in Leprosy and TB , . Awomoyi et al. showed that SLC11A1 (NRAMP1) influenced TB susceptibility by regulating immunosuppressive cytokines such as interleukine-10 (IL-10) , subsequently reducing the Th-1 immune response in the active disease . Several studies have also demonstrated the genetic origin of cytokine deficiencies observed in mycobacterial infections , . In addition, it is known that subjects with past or current M. ulcerans infection mount a dominant Th-2 type response (as also observed in advanced TB , , ) following stimulation with M. ulcerans, while unaffected contacts responded mainly with a Th-1 type response . Thus, the various clinical lesions (nodule, plaque or edema), as well as the resistance to BU, may rely on host factors, such as the type of immune response, that depend on genetic factors. This suggests that patients who develop the clinical disease and those who develop a severe form of the disease appear to have an inherent inability to generate a strong Th-1 response to mycobacterial antigens . Characterizing these primary immunodeficiencies helped to define the Mendelian susceptibility to mycobacterial infections syndrome (MSMIS) , , , . Further studies should explore which human genetic factors play a role in BU infection per se, and in the development of its different clinical forms. This pattern may be of great therapeutic importance.
A gene is inherited in a dominant, recessive or co-dominant mode. Depending on the mode of transmission, the susceptibility to infection can be maintained from one generation to the next in a continuous, discontinuous or even random way. In our study there could be an association between the existence of BU in grandparents and the occurrence of the disease in the study cases (since the p value was at the level of significance (p = 0.06)), whereas there was no association for parents, collaterals or progeny. However, our study lacks precision (95% CI = 0.85–64.08).
Consanguineous marriage is a practice that could promote an imbalance in the transmission of certain genes and thus the development of anomalies. Asha Bai et al. showed that developmental anomalies were significantly more frequent (p<0.001) among the progenies of consanguineous parents . La Rosa, in 2008 , proposed the hypothesis that ethnic endogamy could explain the focal distribution of BU as described in Benin . Lyons et al. showed that consanguinity was an important risk factor in susceptibility to infectious diseases in humans . In particular, they found that cases of TB and hepatitis were more common among inbred individuals, but only in populations where consanguineous marriages are common . Our study does not show any statistical difference in the frequency of consanguineous marriages between the cases and the controls. The overall frequency of the consanguineous marriage practice in our study was only 10.3%. In the cohort of Asha Bai et al. in India, it was 41.4% . However, there is no information on the overall incidence of consanguineous marriages in Benin, sub-Saharan Africa or our study area. Thus, this is an area where further research is needed.
This study confirmed the role of water contact as a risk factor and also suggests that the combination of genetic factors may constitute risk factors for the development of BU. Further studies should explore which human genetic or epigenetic factors play a role in BU infection and the development of the disease.
The authors are grateful to all the participants in this study, the staff of CDTUB Allada. They thank Dr. MT Silva for a critical review of the manuscript and also acknowledge Ms. Guenolé Aude for her contribution during investigations.
Conceived and designed the experiments: GES RCJ MM SYA FP. Performed the experiments: GES YTB ADD. Analyzed the data: GES YTB RCJ ADD MM. Contributed reagents/materials/analysis tools: GES RCJ ADD SYA LK FP. Wrote the paper: GES YTB RCJ ADD MM SYA LK. Coordinated the study: FP SYA. Contributed to the interpretation of the results: FP LK. Contributed to the critical review of the manuscript: FP.
- 1. Janssens PG, Pattyn SR, Meyers WM, Portaels F (2005) Buruli ulcer: an historical overview with updating to 2005. Bull Séanc Acad R Sci Outre-Mer 51: 265–299.PG JanssensSR PattynWM MeyersF. Portaels2005Buruli ulcer: an historical overview with updating to 2005.Bull Séanc Acad R Sci Outre-Mer51265299
- 2. Asiedu K, Etuaful S (1998) Socioeconomic implications of Buruli ulcer in Ghana: a three-year review. Am J Trop Med Hyg 59: 1015–1022.K. AsieduS. Etuaful1998Socioeconomic implications of Buruli ulcer in Ghana: a three-year review.Am J Trop Med Hyg5910151022
- 3. Drummond C, Butler JR (2004) Mycobacterium ulcerans treatment costs, Australia. Emerg Infect Dis 10: 1038–1043.C. DrummondJR Butler2004Mycobacterium ulcerans treatment costs, Australia.Emerg Infect Dis1010381043
- 4. Asiedu K, Scherpbier RW, Raviglione M (2000) Buruli ulcer. WHO/CDS/GBUI Geneva 1–160.K. AsieduRW ScherpbierM. Raviglione2000Buruli ulcer.WHO/CDS/GBUI Geneva1160
- 5. Stinear T, Johnson PDR (2008) First isolation of Mycobacterium ulcerans from an aquatic environment: the end of a 60-year search? PLoS Negl Trop Dis 2: e216, 1–2.T. StinearPDR Johnson2008First isolation of Mycobacterium ulcerans from an aquatic environment: the end of a 60-year search?PLoS Negl Trop Dis2e216, 12
- 6. Portaels F, Meyers WM, Ablordey A, Castro AG, Chemlal K, et al. (2008) First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis 2: e178, 1–12.F. PortaelsWM MeyersA. AblordeyAG CastroK. Chemlal2008First cultivation and characterization of Mycobacterium ulcerans from the environment.PLoS Negl Trop Dis2e178, 112
- 7. Portaels F, Silva MT, Meyers WM (2009) Buruli ulcer. Clin Dermatol 27: 291–305.F. PortaelsMT SilvaWM Meyers2009Buruli ulcer.Clin Dermatol27291305
- 8. Prevot G, Bourreau E, Pascalis H, Pradinaud R, Tanghe A, et al. (2004) Differential production of systemic and intralesional gamma interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease. Infect Immun 72: 958–965.G. PrevotE. BourreauH. PascalisR. PradinaudA. Tanghe2004Differential production of systemic and intralesional gamma interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease.Infect Immun72958965
- 9. Okenu DM, Ofielu LO, Easley KA, Guarner J, Spotts Whitney EA, et al. (2004) Immunoglobulin M antibody responses to Mycobacterium ulcerans allow discrimination between cases of active Buruli ulcer disease and matched family controls in areas where the disease is endemic. Clin Diagn Lab Immunol 11: 387–391.DM OkenuLO OfieluKA EasleyJ. GuarnerEA Spotts Whitney2004Immunoglobulin M antibody responses to Mycobacterium ulcerans allow discrimination between cases of active Buruli ulcer disease and matched family controls in areas where the disease is endemic.Clin Diagn Lab Immunol11387391
- 10. Gooding TM, Johnson PD, Smith M, Kemp AS, Robins-Browne RM (2002) Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts. Infect Immun 70: 5562–5567.TM GoodingPD JohnsonM. SmithAS KempRM Robins-Browne2002Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts.Infect Immun7055625567
- 11. World Health Organization (2004) Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). World Health Organization2004Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer).WHO/CDS/CPE/GBUI.10, Geneva. WHO/CDS/CPE/GBUI.10, Geneva.
- 12. World Health Organization (2001) Buruli ulcer. In: Portaels F, Johnson P, Meyers WM, editors. Geneva: World Health Organization: 92. World Health Organization2001Buruli ulcer.F. PortaelsP. JohnsonWM MeyersGenevaWorld Health Organization: 92Diagnosis of Mycobacterium ulcerans disease. A manual for health care providers. Diagnosis of Mycobacterium ulcerans disease. A manual for health care providers.
- 13. Sizaire V, Nackers F, Comte E, Portaels F (2006) Mycobacterium ulcerans infection: control, diagnosis, and treatment. Lancet Infect Dis 6: 288–296.V. SizaireF. NackersE. ComteF. Portaels2006Mycobacterium ulcerans infection: control, diagnosis, and treatment.Lancet Infect Dis6288296
- 14. Duker AA, Portaels F, Hale M (2006) Pathways of Mycobacterium ulcerans infection: a review. Environ Int 32: 567–573.AA DukerF. PortaelsM. Hale2006Pathways of Mycobacterium ulcerans infection: a review.Environ Int32567573
- 15. Merritt RW, Benbow ME, Small PLC (2005) Unraveling an emerging disease associated with disturbed aquatic environments: the case of Buruli ulcer. Front Ecol Environ; 3: 323–331.RW MerrittME BenbowPLC Small2005Unraveling an emerging disease associated with disturbed aquatic environments: the case of Buruli ulcer.Front Ecol Environ;3323331
- 16. Lunn HF, Connor DH, Wilks NE, Barnley GR, Kamunvi F, et al. (1965) Buruli (mycobacterial) ulceration in Uganda (a new focus of Buruli ulcer in Madi district, Uganda): report of a field study. East Afr Med J 42: 275–88.HF LunnDH ConnorNE WilksGR BarnleyF. Kamunvi1965Buruli (mycobacterial) ulceration in Uganda (a new focus of Buruli ulcer in Madi district, Uganda): report of a field study.East Afr Med J4227588
- 17. Barker DJ (1972) The distribution of Buruli disease in Uganda. Trans R Soc Trop Med Hyg 66: 867–874.DJ Barker1972The distribution of Buruli disease in Uganda.Trans R Soc Trop Med Hyg66867874
- 18. Ravisse P (1977) [Skin ulcer caused by Mycobacterium ulcerans in Cameroon: clinical, epidemiological and histological study]. Bull Soc Pathol Exot Filiales 70: 109–124. French.P. Ravisse1977[Skin ulcer caused by Mycobacterium ulcerans in Cameroon: clinical, epidemiological and histological study].Bull Soc Pathol Exot Filiales70109124. French
- 19. Oluwasanmi JO, Solanke TF, Olurin EO, Itayemi SO, Alabi GO, et al. (1976) Mycobacterium ulcerans (Buruli) skin ulceration in Nigeria. Am J Trop Med Hyg 25: 122–128.JO OluwasanmiTF SolankeEO OlurinSO ItayemiGO Alabi1976Mycobacterium ulcerans (Buruli) skin ulceration in Nigeria.Am J Trop Med Hyg25122128
- 20. Johnson RC, Makoutodé M, Sopoh G, Elsen P, Gbovi J, et al. (2005) Buruli ulcer distribution in Benin. Emerg Inf Dis 11: 500–501.RC JohnsonM. MakoutodéG. SopohP. ElsenJ. Gbovi2005Buruli ulcer distribution in Benin.Emerg Inf Dis11500501
- 21. Kibadi K, Panda M, Tamfum JJ, Fraga AG, Longatto Filho A, et al. (2008) New foci of Buruli ulcer, Angola and Democratic Republic of Congo. Emerg Infect Dis 14: 1790–1792.K. KibadiM. PandaJJ TamfumAG FragaA. Longatto Filho2008New foci of Buruli ulcer, Angola and Democratic Republic of Congo.Emerg Infect Dis1417901792
- 22. Kotlowski R, Martin A, Ablordey A, Chemlal K, Fonteyne PA, et al. (2004) One-tube cell lysis and DNA extraction procedure for PCR-based detection of Mycobacterium ulcerans in aquatic insects, molluscs and fish. J Med Microbiol 53: 927–933.R. KotlowskiA. MartinA. AblordeyK. ChemlalPA Fonteyne2004One-tube cell lysis and DNA extraction procedure for PCR-based detection of Mycobacterium ulcerans in aquatic insects, molluscs and fish.J Med Microbiol53927933
- 23. Eddyani M, Ofori-Adjei D, Teugels G, DE Weirdt D, Boakye D, et al. (2004) Potential Role for Fish in Transmission of Mycobacterium ulcerans Disease (Buruli Ulcer): an environmental study. Appl Environ Microbiol 70: 5679–5681.M. EddyaniD. Ofori-AdjeiG. TeugelsD. DE WeirdtD. Boakye2004Potential Role for Fish in Transmission of Mycobacterium ulcerans Disease (Buruli Ulcer): an environmental study.Appl Environ Microbiol7056795681
- 24. Portaels F, Chemlal K, Elsen P, Johnson PD, Hayman JA, et al. (2001) Mycobacterium ulcerans in wild animals. Rev Sci Tech 20: 252–264.F. PortaelsK. ChemlalP. ElsenPD JohnsonJA Hayman2001Mycobacterium ulcerans in wild animals.Rev Sci Tech20252264
- 25. Raghunathan PL, Whitney EA, Asamoa K, Stienstra Y, Taylor TH Jr, et al. (2005) Risk factors for Buruli ulcer disease (Mycobacterium ulcerans infection): results from a case-control study in Ghana. Clin Infect Dis 40: 1445–1453.PL RaghunathanEA WhitneyK. AsamoaY. StienstraTH Taylor Jr2005Risk factors for Buruli ulcer disease (Mycobacterium ulcerans infection): results from a case-control study in Ghana.Clin Infect Dis4014451453
- 26. Aiga H, Amano T, Cairncross S, Adomako J, Nanas OK, et al. (2004) Assessing water-related risk factors for Buruli ulcer: a case-control study in Ghana. Am J Trop Med Hyg 71: 387–392.H. AigaT. AmanoS. CairncrossJ. AdomakoOK Nanas2004Assessing water-related risk factors for Buruli ulcer: a case-control study in Ghana.Am J Trop Med Hyg71387392
- 27. Pouillot R, Matias G, Mbondji Wondje C, Portaels F, Valin N, et al. (2007) Risk factors for Buruli ulcer: a case control study in Cameroon. Plos Neg Trop Dis 1: e101.R. PouillotG. MatiasC. Mbondji WondjeF. PortaelsN. Valin2007Risk factors for Buruli ulcer: a case control study in Cameroon.Plos Neg Trop Dis1e101
- 28. Debacker M, Portaels F, Aguiar J, Steunou C, Zinsou C, et al. (2006) Risk factors for Buruli ulcer, Benin. Emerg Infect Dis 12: 1325–1331.M. DebackerF. PortaelsJ. AguiarC. SteunouC. Zinsou2006Risk factors for Buruli ulcer, Benin.Emerg Infect Dis1213251331
- 29. Nackers F, Johnson RC, Glynn JR, Zinsou C, Tonglet R, et al. (2007) Environmental and health-related risk factors for Mycobacterium ulcerans disease (Buruli ulcer) in Benin. Am J Trop Med Hyg 77: 834–836.F. NackersRC JohnsonJR GlynnC. ZinsouR. Tonglet2007Environmental and health-related risk factors for Mycobacterium ulcerans disease (Buruli ulcer) in Benin.Am J Trop Med Hyg77834836
- 30. Marston BJ, Diallo MO, Horsburgh CR JR, Diomande I, Saki MZ, et al. (1995) Emergence of Buruli ulcer disease in the Daloa region of Côte d'Ivoire. Am J Trop Med Hyg 52: 219–224.BJ MarstonMO DialloJR Horsburgh CRI. DiomandeMZ Saki1995Emergence of Buruli ulcer disease in the Daloa region of Côte d'Ivoire.Am J Trop Med Hyg52219224
- 31. Siddiqui MR, Meisner S, Tosh K, Balakrishnan K, Ghei S, et al. (2001) A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat Genet 27: 439–441.MR SiddiquiS. MeisnerK. ToshK. BalakrishnanS. Ghei2001A major susceptibility locus for leprosy in India maps to chromosome 10p13.Nat Genet27439441
- 32. Alcaïs A, Mira M, Casanova JL, Schurr E, Abel L (2005) Genetic dissection of immunity in leprosy. Curr Opin Immunol 17: 44–48.A. AlcaïsM. MiraJL CasanovaE. SchurrL. Abel2005Genetic dissection of immunity in leprosy.Curr Opin Immunol174448
- 33. Mira MT, Alcaïs A, Van Thuc N, Thai VH, Huong NT, et al. (2003) Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat Genet 33: 412–415.MT MiraA. AlcaïsN. Van ThucVH ThaiNT Huong2003Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population.Nat Genet33412415
- 34. Mira MT, Alcaïs A, Nguyen VT, Moraes MO, Di Flumeri C (2004) Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427: 636–640.MT MiraA. AlcaïsVT NguyenMO MoraesC. Di Flumeri2004Susceptibility to leprosy is associated with PARK2 and PACRG.Nature427636640
- 35. Casanova JL, Abel L (2007) Human genetics of infectious diseases: a unified theory. EMBO J 26: 915–922.JL CasanovaL. Abel2007Human genetics of infectious diseases: a unified theory.EMBO J26915922
- 36. Casanova JL, Abel L (2002) Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 20: 581–620.JL CasanovaL. Abel2002Genetic dissection of immunity to mycobacteria: the human model.Annu Rev Immunol20581620
- 37. Baghdadi JE, Orlova M, Alter A, Ranque B, Chentoufi M (2006) An autosomal dominant major gene confers predisposition to pulmonary tuberculosis in adults. J Exp Med 203: 1679–1684.JE BaghdadiM. OrlovaA. AlterB. RanqueM. Chentoufi2006An autosomal dominant major gene confers predisposition to pulmonary tuberculosis in adults.J Exp Med20316791684
- 38. Alcaïs A, Alter A, Antoni G, Orlova M, Nguyen VT (2007) Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early-onset leprosy. Nat Genet 39: 517–22.A. AlcaïsA. AlterG. AntoniM. OrlovaVT Nguyen2007Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early-onset leprosy.Nat Genet3951722
- 39. Stienstra Y, van der Graaf WTA, te Meerman GJ, The TH, de Leij LF, et al. (2001) Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors. Trop Med Int Health 6: 554–562.Y. StienstraWTA van der GraafGJ te MeermanTH TheLF de Leij2001Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors.Trop Med Int Health6554562
- 40. Stienstra Y, van der Werf TS, Oosterom E, Nolte IM, van der Graaf WT, et al. (2006) Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism. Genes Immun 7: 185–189.Y. StienstraTS van der WerfE. OosteromIM NolteWT van der Graaf2006Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism.Genes Immun7185189
- 41. Awomoyi AA, Marchant A, Howson JM, Mcadam KP, Blackwell JM, et al. (2002) Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J Infect Dis 186: 1808–1814.AA AwomoyiA. MarchantJM HowsonKP McadamJM Blackwell2002Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis.J Infect Dis18618081814
- 42. Catherinot E, Fieschi C, Feinberg J, Casanova JL, Couderc LJ (2005) [Genetic susceptibility to mycobacterial disease: Mendelian disorders of the interleukin-12 -interferon-gamma axis]. Rev Mal Respir 22: 767–776. French.E. CatherinotC. FieschiJ. FeinbergJL CasanovaLJ Couderc2005[Genetic susceptibility to mycobacterial disease: Mendelian disorders of the interleukin-12 -interferon-gamma axis].Rev Mal Respir22767776. French
- 43. Picard C, Fieschi C, Altare F, Al-Jumaah S, Al-Hajjar S, et al. (2002) Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 70: 336–348.C. PicardC. FieschiF. AltareS. Al-JumaahS. Al-Hajjar2002Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds.Am J Hum Genet70336348
- 44. Gooding TM, Johnson PD, Campbell DE, Hayman JA, Hartland EL, et al. (2001) Immune response to infection with Mycobacterium ulcerans. Infect Immun 69: 1704–1707.TM GoodingPD JohnsonDE CampbellJA HaymanEL Hartland2001Immune response to infection with Mycobacterium ulcerans.Infect Immun6917041707
- 45. Silva MT, Portaels F, Pedrosa J (2009) Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer. Lancet Infect Dis 9: 699–710.MT SilvaF. PortaelsJ. Pedrosa2009Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.Lancet Infect Dis9699710
- 46. Alcaïs A, Abel L, Casanova JL (2009) Human genetics of infectious diseases: between proof of principle and paradigm. J Clin Invest 119: 2506–2514.A. AlcaïsL. AbelJL Casanova2009Human genetics of infectious diseases: between proof of principle and paradigm.J Clin Invest11925062514
- 47. Casanova JL (2001) Mendelian susceptibility to mycobacterial infection in man. Swiss Med Wkly 131: 445–454.JL Casanova2001Mendelian susceptibility to mycobacterial infection in man.Swiss Med Wkly131445454
- 48. Asha Bai PV, John TJ, Subramaniam VR (1981) Reproductive wastage and developmental disorders in relation to consanguinity in south India. Trop Geogr Med 33: 275–280.PV Asha BaiTJ JohnVR Subramaniam1981Reproductive wastage and developmental disorders in relation to consanguinity in south India.Trop Geogr Med33275280
- 49. La Rosa FMD (2008) [Ethnic endogamy and Buruli ulcer: is there a relationship?]. Bull de l'ALLF 23: 60. French.FMD La Rosa2008[Ethnic endogamy and Buruli ulcer: is there a relationship?].Bull de l'ALLF2360. French
- 50. Lyons EJ, Frodsham AJ, Zhang L, Hill AV, Amos W (2009) Consanguinity and susceptibility to infectious diseases in humans. Biol Lett 5: 574–576.EJ LyonsAJ FrodshamL. ZhangAV HillW. Amos2009Consanguinity and susceptibility to infectious diseases in humans.Biol Lett5574576